Publications

Kirii Y, Magarian-Blander J, Alter MD, Kotera Y, Finn OJ. Functional and molecular analysis of T cell receptors used by pancreatic- and breast tumor- (mucin-) specific cytotoxic T cells. J Immunother. 1998;21(3):188-97.

Magarian-Blander J, Ciborowski P, Hsia S, Watkins SC, Finn OJ. Intercellular and intracellular events following the MHC-unrestricted TCR recognition of a tumor-specific peptide epitope on the epithelial antigen MUC1. J Immunol. 1998;160(7):3111-20.

Ciborowski P, Konitzki WM, Blander JM, Finn OJ. Screening of anti-MUC1 antibodies for reactivity with native (ascites) and recombinant (baculovirus) MUC1 and for blocking MUC1 specific cytotoxic T-lymphocytes. Tumour Biol. 1998;19 Suppl 1:147-51.

Poland PA, Kinlough CL, Rokaw MD, Magarian-Blander J, Finn OJ, Hughey RP. Differential glycosylation of MUC1 in tumors and transfected epithelial and lymphoblastoid cell lines. Glycoconj J. 1997;14(1):89-96.

Magarian-Blander J, Hughey RP, Kinlough C, Poland PA, Finn OJ. Differential expression of MUC1 on transfected cell lines influences its recognition by MUC1 specific T cells. Glycoconj J. 1996;13(5):749-56.